India has paused talks on a bilateral trade agreement with the US, citing one-sided demands and a lack of reciprocal benefits. The rejection centers on US tariff actions, including Section 122 and 301 investigations, which create uncertainty for Indian exporters. With the US Supreme Court invalidating previous tariff concessions, the trade landscape remains volatile for companies with high exposure to the US market.
What Happened
India has effectively put a halt to negotiations for an interim trade agreement with the United States. Following the recent departure of United States Trade Representative Jamieson Greer, New Delhi has signaled that the current framework of the proposed deal is unacceptable. The primary point of contention is a push from the US side for India to lower tariffs on various imports without providing meaningful, equivalent trade concessions in return. India is instead prioritizing safeguards to protect its industries against unilateral tariff actions, while also seeking market access terms that align with those granted to competing nations.
The Tariff Tension
The proposed framework appeared to prioritize US export interests, including demands for India to reduce tariffs on numerous product categories. In exchange, the US offered limited reductions on specific retaliatory tariffs. However, the value of these concessions has been called into question. New Delhi is also wary of US tactics involving Section 122 of the Trade Act of 1974, which allows for temporary 10 percent tariffs on all imports. Furthermore, US-initiated investigations under Section 301 create a risk of future unilateral trade barriers, which could hurt Indian exporters of goods and services.
Why The US Supreme Court Ruling Matters
A pivotal legal development has significantly changed the negotiating landscape. On February 20, 2026, the US Supreme Court issued a ruling that invalidated reciprocal tariffs. This decision undermines the primary concession the US had reportedly offered to India—a reduction in retaliatory tariffs. With the legal foundation for those tariffs removed, the US effectively has fewer meaningful concessions to offer, making the original trade deal draft even less attractive to Indian negotiators.
Impact on Indian Exporters
Trade uncertainty can directly impact companies with significant exposure to the US. In FY26, India’s exports to the US showed resilience, growing by 1 percent to reach $87.3 billion. Sectors such as IT services, pharmaceuticals, textiles, and medical devices maintain a large presence in the US market. Any escalation in trade friction or new tariff barriers could affect the profit margins of these export-oriented companies. While the services trade remains relatively balanced, the ongoing discussions regarding goods trade and non-tariff barriers, particularly for agricultural and medical products, remain sensitive areas for investors to track.
What Investors Should Monitor
The immediate focus for investors is how this rejection impacts bilateral trade relations. The key monitorable is whether the US shifts its stance to offer more balanced terms or if it continues to rely on Section 301 investigations as a negotiation tool. Investors should watch for official statements from the Ministry of Commerce and Industry regarding any resumption of talks or changes to trade policy. Additionally, tracking any new updates regarding Section 122 tariffs—which are currently set to expire on July 24—will be essential to understanding the short-term pressure on trade costs for Indian companies.